Medline Industries wants 1 of its insurers to cover the $500,000 it expects to log in legal fees defending against lawsuits filed over its purchase of counterfeit surgical mesh from RAM Medical.
Wayne, N.J.-based medical device distributor RAM Medical admitted in December 2011 to importing and reselling counterfeit and contaminated surgical hernia mesh products.
The FDA had warned in June 2011 that fake versions of the product, commonly known as Marlex mesh, should not be used. Investigations by the FDA and Bard found most of the counterfeit product was labeled with genuine Bard lot numbers.
Sign up to get our free newsletters delivered right to your inbox
Leading back as far as October 2008, RAM purchased from sellers in the United Arab Emirates and Delhi, India surgical mesh falsely branded as made by Bard subsidiary Davol Inc.
The fakes were sold to 7 RAM customers, owner and president Richard Mazon revealed during the Dept. of Justice investigation. Many boxes sold between December 2008 and June 2009 were contaminated with microorganisms.
The company agreed to make full restitution for the value of the fake mesh products to its customers or any other companies who purchased them, according to a DOJ press release, and as a special condition of its probation RAM will track down and destroy all of the counterfeit mesh it imported.
Each of the 2 counts against the company carries a maximum penalty of 5 years of probation as well as maximum fines of $200,000 or twice the gain or loss caused by the offense. Sentencing is scheduled for March 8, 2012.
Illinois-based medical products supplier Medline Industries filed a case against RAM after facing lawsuits over the fake mesh. Medline’s suit argues that RAM should be held responsible for legal bills it racks up defending itself, Law360.com reported. Both Medline and RAM are facing at least 5 lawsuits, including 2 class actions, and more suits may be in the works.
The FDA first issued warnings about counterfeit surgical mesh circulating in the U.S. market in March 2010.
